Healthy Skepticism Library item: 4019

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

MaLAM letter follow up—Merck Sharp & Dohme. Are MSD’s distributors uncontrollable?
MaLAM Newsletter 1989 Nov;

Abstract:

MaLAM does not accept Merck’s position that it cannot control the way that its Penstrep distributor behaves. MaLAM argues that Merck could buy back the rights to Penstrep.

Keywords:
*analysis/Thailand/developing countries/Merck/Penstrep/company responses/MaLAM/Medical Lobby for Appropriate Marketing/antibiotics/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: ANTIBIOTICS